We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

13 hedge funds and large institutions have $1.57M invested in Indaptus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

0.16% less ownership

Funds ownership: 6.95% → 6.79% (-0.16%)

7% less funds holding

Funds holding: 14 → 13 (-1)

56% less capital inflows, than outflows

Capital inflows: $20.3K | Capital outflows: $45.7K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.3K
2
Renaissance Technologies
Renaissance Technologies
New York
+$8.65K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$946
4
Morgan Stanley
Morgan Stanley
New York
+$473

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$24.7K
2
Investment House LLC
Investment House LLC
California
-$13.1K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$6.35K
4
UBS Group
UBS Group
Switzerland
-$1.22K
5
Pine Valley Investments
Pine Valley Investments
New Jersey
-$405

INDP Hedge Fund Activity: Q3 2023 in Review

13 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q3 2023, worth a combined $1.57M — up 41% from $1.11M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of INDP and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Geode Capital Management, adding an estimated $10.3K. The largest seller was Northern Trust, exiting entirely with an estimated $24.7K sold.

  • 13 institutional investors held Indaptus Therapeutics (INDP) as of Q3 2023, down from 14 in Q2 2023.
  • Funds reported $1.57M of Indaptus Therapeutics stock for Q3 2023, up 41% quarter-over-quarter.
  • 0 funds opened new Indaptus Therapeutics positions in Q3 2023 and 1 closed out, a net change of -1 holder.
  • The largest Indaptus Therapeutics buyer in Q3 2023 was Geode Capital Management, an estimated $10.3K added.
  • The largest Indaptus Therapeutics seller in Q3 2023 was Northern Trust, an estimated $24.7K sold.

Based on aggregated 13F filings for Q3 2023.